ArticleLifestyle genomics2025
Uncoupling Proteins Variants Are Linked to Hypercholesterolemia and Abdominal Obesity in Metabolically Unhealthy Women.
Article in Lifestyle genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the Scale: How Metabolic Context Reveals Hidden Genetic Risks.Lifestyle genomics · 2026Article
Corrections and comments
- Erratum issuedErratum.2025
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIt has been reported that even with the same body mass index (BMI); there are subjects with metabolically healthy (MH) or unhealthy (MUH) phenotype. The main determinants of the unhealthy phenotype are the type and distribution of fat, ectopic fat accumulation, genetics, and lifestyle factors. Uncoupling proteins (UCPs) disengage mitochondrial respiration from ATP synthesis and result in heat production, which in turn is related to energy expenditure and, thus, to fat mass accumulation. The association of the UCP1 3826A/G (rs1800592), UCP2 Ala55Val (rs660339), and UCP3 55C/T (rs1800849) variants with metabolic variables was evaluated according to metabolic phenotype in Mexican women.
methodsWomen aged 18-65 years classified as normal weight (NW) or excessive weight (EW) according to their BMI (from 18.5 to <25 kg/m2 for NW, and from 25 to <40 kg/m2 for EW), were included. Participants were classified into two metabolic phenotypes: MH or MUH, respectively, based on ATP-III criteria and the homeostasis model assessment of insulin resistance (HOMA-IR). The genetic variants were determined by allelic discrimination using TaqMan® probes.
resultsIn participants with the UCP1 3826A/G variant, an increased risk of hypercholesterolemia was observed in those with the NW-MUH phenotype (OR = 5.09, 95% CI = 1.03-25.12, p = 0.017). The UCP2 Ala55Val variant in EW-MUH subjects was associated with higher abdominal obesity risk (OR = 3.23, 95% CI = 1.21-8.60, p = 0.019), while no associations were found with the UCP3 55C/T variant.
conclusionUCP1 and UCP2 variants are related with hypercholesterolemia and visceral fat accumulation in women with MUH phenotype.
introductionIt has been reported that even with the same body mass index (BMI); there are subjects with metabolically healthy (MH) or unhealthy (MUH) phenotype. The main determinants of the unhealthy phenotype are the type and distribution of fat, ectopic fat accumulation, genetics, and lifestyle factors. Uncoupling proteins (UCPs) disengage mitochondrial respiration from ATP synthesis and result in heat production, which in turn is related to energy expenditure and, thus, to fat mass accumulation. The association of the UCP1 3826A/G (rs1800592), UCP2 Ala55Val (rs660339), and UCP3 55C/T (rs1800849) variants with metabolic variables was evaluated according to metabolic phenotype in Mexican women.
methodsWomen aged 18-65 years classified as normal weight (NW) or excessive weight (EW) according to their BMI (from 18.5 to <25 kg/m2 for NW, and from 25 to <40 kg/m2 for EW), were included. Participants were classified into two metabolic phenotypes: MH or MUH, respectively, based on ATP-III criteria and the homeostasis model assessment of insulin resistance (HOMA-IR). The genetic variants were determined by allelic discrimination using TaqMan® probes.
resultsIn participants with the UCP1 3826A/G variant, an increased risk of hypercholesterolemia was observed in those with the NW-MUH phenotype (OR = 5.09, 95% CI = 1.03-25.12, p = 0.017). The UCP2 Ala55Val variant in EW-MUH subjects was associated with higher abdominal obesity risk (OR = 3.23, 95% CI = 1.21-8.60, p = 0.019), while no associations were found with the UCP3 55C/T variant.
conclusionUCP1 and UCP2 variants are related with hypercholesterolemia and visceral fat accumulation in women with MUH phenotype.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.